Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Smartphone Microscopic Method Detects Cryptosporidium and Giardia

By LabMedica International staff writers
Posted on 30 Sep 2020
Food and water-borne illness arising from the consumption of contaminated food and water are serious health hazards globally. More...
Cryptosporidium and Giardia are the major food and water‒borne parasites. The infection occurs mainly by (oo)cyst phase of the parasites.

Several highly sensitive and specific methods have been described to detect Giardia cyst and Cryptosporidium oocyst in food, water, and fecal samples. Commonly used approaches are polymerase chain reaction, flow cytometry, and optical microscopic examination. However, these techniques need a good laboratory facility, well trained user and are expensive.

Scientists at the Kathmandu Institute of Applied Sciences (Kathmandu, Nepal) developed a smartphone based microscopic assay method to screen (oo)cysts of Cryptosporidium and Giardia contamination of vegetable and water samples. The method consisting of a ball lens of 1 mm diameter, white LED as illumination source and Lugols's iodine staining provided magnification and contrast capable of distinguishing (oo)cysts of Cryptosporidium and Giardia. The analytical performance of the method was tested by spike recovery studies.

Ten microliters of concentrated sample were stained with 10 μL of diluted Lugol's iodine (1:2 in water) and subsequently loaded into hemocytometer. The sample was incubated for six minutes. The (oo)cysts were screened and enumerated in four quadrants of the hemocytometer under smartphone microscope. The cysts on the same hemocytometer were simultaneously counted by Trinocular brightfield microscope (Amscope, Irvine, CA, USA). Triplicate measurement was made for each concentrated suspension. The spiked samples were also examined with a fluorescent microscope (Labomed Inc, Los Angeles, CA, USA).

The team tested the smartphone microscope system for detecting (oo)cysts on seven types of vegetable (n = 196) and river water (n = 18) samples. They reported that 42% vegetable and 39% water samples were found to be contaminated with Cryptosporidium oocyst. Similarly, 31% vegetable and 33% water samples were contaminated with Giardia cyst. The recovery of Giardia ranged from 10.2 ± 4.0% in cabbage to 37.6 ± 2.4% in water and recovery of Cryptosporidium ranged from 26.8 ± 10.3% in cabbage to 49.2 ± 10.9% in tomato using smartphone microscope measurement.

The authors concluded that the smartphone based microscopic assay can be a low-cost alternative for screening of (oo)cyst of Cryptosporidium and Giardia in resource limited settings. The approximate cost of the microscope (excluding the cost of smartphone) is ~ USD 15. This method also has the potential to be used in clinical settings. The study was published on September 8, 2020 in the journal PLOS Neglected Tropical Diseases.

Related Links:
Kathmandu Institute of Applied Sciences
Amscope
Labomed Inc



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: LVOne uses blood-based biomarkers to detect stroke and identify large vessel occlusion before hospital arrival, providing objective results earlier than traditional assessments. (Photo courtesy of UpFront Diagnostics)

First-of-Its-Kind Rapid Blood Test Gains CE Mark to Support Prehospital Stroke Triage

Rapid stroke identification before hospital arrival is critical because treatment efficacy declines with every minute of delay. However, definitive assessment typically requires hospital-based imaging,... Read more

Molecular Diagnostics

view channel
Image: The proposed workflow adds liquid biopsy to detect genetic and molecular signs of cancer in CSF samples already collected during autoimmune encephalitis evaluation. (Image Credit: Shutterstock)

CSF Liquid Biopsy Could Help Distinguish Cancer from Autoimmune Brain Inflammation

Autoimmune encephalitis can cause memory and behavioral changes, seizures, and altered consciousness, but diagnosis can be challenging because cancers involving the brain and central nervous system may... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Ebola remains a rapidly evolving public health threat with high mortality, underscoring the need for timely diagnosis and decentralized testing closer to patients (Image Credit: Adobe Stock)

Collaboration Targets Blood-Based Ebola Detection Outside Central Laboratories

Co-Diagnostics, Inc. (Salt Lake City, UT, USA) and ReadyGo Diagnostics Ltd. (Bath, UK) have initiated a collaboration to evaluate ReadyGo’s GoCollect with the Co-Dx PCR platform for blood-based molecular... Read more

Industry

view channel
Image: Galleri is designed to detect cancer-specific methylation patterns across multiple cancer types before symptoms appear, including cancers without recommended screening (Photo courtesy of GRAIL)

Multi-Cancer Early Detection Test Wins FDA Panel Backing for Approval

GRAIL’s Galleri multi-cancer early detection (MCED) test was reviewed by the Molecular and Clinical Genetics Devices Panel of the U.S. Food and Drug Administration’s (FDA) Medical Devices Advisory Committee.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.